How the Immune System Turned Against Itself in Children with MIS-C
A study uncovers how an autoimmune response triggered by COVID-19 leads to multisystem inflammatory syndrome in children.
A study uncovers how an autoimmune response triggered by COVID-19 leads to multisystem inflammatory syndrome in children.
A study uncovers how an autoimmune response triggered by COVID-19 leads to multisystem inflammatory syndrome in children.
Read MoreEven when the oxygen level is normal, inflammation and the reaction to hypoxia are connected; the key is individual sensitivity to hypoxia.
Read MoreChildren with multisystem inflammatory syndrome (MIS-C) have biochemical indicators of cell injury and cell death that are distinct from other children with COVID-19.
Read MoreEight NIH grants will fund research to refine new technologies for rapid diagnosis of multisystem inflammatory syndrome in children (MIS-C).
Read MoreA study finds no serious complications following COVID-19 vaccine after multisystem inflammatory syndrome, a rare immune condition.
Read MoreAt least two months after hospitalization with acute COVID-19 or multisystem inflammatory syndrome in children (MIS-C), more than 25 percent experience persistent symptoms or activity impairment.
Read MoreCovid-19 complications among children are fading with the latest COVID wave and multisystem inflammatory syndrome (MIS-C) might become a thing of the past.
Read MoreAs MIS-C rates rose, physicians began to note its similarities to a pre-pandemic illness, Kawasaki disease, which has puzzled pediatricians for more than 50 years.
Read MoreA new study by physicians at Columbia University Vagelos College of Physicians and Surgeons has identified unique features of MIS-C, a rare but potentially deadly complication of COVID in children, that suggest how the syndrome gets started.
Read MoreWhile MIS-C is rare, the Centers for Disease Control and Prevention has documented over 6,400 MIS-C cases and 55 deaths as of January.
Read MoreThroughout the pandemic, MIS-C has followed a predictable pattern, sending waves of children to the hospital about a month after a covid surge.
Read MoreIntravenous immune globulin—a common treatment for multisystem inflammatory syndrome in children (MIS-C)—likely works by depleting immune cells called neutrophils.
Read MorePatient with multisystem inflammatory syndrome in children treated initially with intravenous immune globulin and glucocorticoids had reduced risk for serious short-term outcomes than those treated with IVIG alone.
Read MoreNeck inflammation is common in multisystem inflammatory syndrome in children, new research in the Journal of the Pediatric Infectious Diseases Society found.
Read MoreMany children who develop multisystem inflammatory syndrome (MIS-C) see their most serious symptoms diminish after six months, new research shows.
Read MoreEarly findings of a small study suggest that children who had coronavirus-linked MIS-C also developed neurological symptoms.
Read MoreResearchers are investigating if saliva samples contain markers of MIS-C, which could help physicians test earlier and prevent severe disease.
Read MoreAs cases of multisystem inflammatory syndrome in children (MIS-C) continue to rise, a report from USA Today details the account of one 12-year-old boy who became sick with the condition.
Read MoreA report by the Los Angeles Times describes how the total number of children experiencing multisystem inflammatory syndrome (MIS-C) is growing in Los Angeles County.
Read MoreAn NIAID study will enroll at least 250 children and young adults to learn the effects of SARS-CoV-2 and multisystem inflammatory syndrome in children (MIS-C).
Read MoreWhile most children who get COVID-19 develop little more than a mild illness, several hundred have ended up in hospital intensive care units with alarming symptoms that begin appearing weeks after the initial infection.
Read More